JP2013535477A5 - - Google Patents

Download PDF

Info

Publication number
JP2013535477A5
JP2013535477A5 JP2013522132A JP2013522132A JP2013535477A5 JP 2013535477 A5 JP2013535477 A5 JP 2013535477A5 JP 2013522132 A JP2013522132 A JP 2013522132A JP 2013522132 A JP2013522132 A JP 2013522132A JP 2013535477 A5 JP2013535477 A5 JP 2013535477A5
Authority
JP
Japan
Prior art keywords
polyethylene glycol
noge
emissions
mpa
ion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013522132A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013535477A (ja
JP5937593B2 (ja
Filing date
Publication date
Priority claimed from EP10008104A external-priority patent/EP2415460A1/de
Application filed filed Critical
Publication of JP2013535477A publication Critical patent/JP2013535477A/ja
Publication of JP2013535477A5 publication Critical patent/JP2013535477A5/ja
Application granted granted Critical
Publication of JP5937593B2 publication Critical patent/JP5937593B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013522132A 2010-08-03 2011-08-02 プレガバリンの経口投与剤形 Active JP5937593B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10008104.1 2010-08-03
EP10008104A EP2415460A1 (de) 2010-08-03 2010-08-03 Orale Darreichungsform von Pregabalin
PCT/EP2011/003873 WO2012016683A2 (en) 2010-08-03 2011-08-02 Oral dosage form of pregabalin

Publications (3)

Publication Number Publication Date
JP2013535477A JP2013535477A (ja) 2013-09-12
JP2013535477A5 true JP2013535477A5 (enExample) 2016-02-18
JP5937593B2 JP5937593B2 (ja) 2016-06-22

Family

ID=43216378

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013522132A Active JP5937593B2 (ja) 2010-08-03 2011-08-02 プレガバリンの経口投与剤形

Country Status (6)

Country Link
US (1) US20130149253A1 (enExample)
EP (2) EP2415460A1 (enExample)
JP (1) JP5937593B2 (enExample)
KR (1) KR20140003376A (enExample)
CA (1) CA2806752A1 (enExample)
WO (1) WO2012016683A2 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013100874A1 (en) * 2011-12-19 2013-07-04 Mahmut Bilgic Effervescent pregablin formulation
EP2849733B1 (en) * 2011-12-19 2020-04-08 Mahmut Bilgic Effervescent pharmaceutical formulations comprising pregabalin and vitamin b12
WO2013100873A1 (en) * 2011-12-19 2013-07-04 Mahmut Bilgic Pharmaceutical formulation of pregabalin (particle size 300-2500 micrometer)
MX2013001278A (es) * 2013-01-31 2014-07-30 Miguel Ángel García Pérez Composicion farmaceutica con un sistema bifasico de liberacion inmediata para el control de eventos convulsivos y del dolor.
WO2015114655A2 (en) * 2014-01-21 2015-08-06 Intas Pharmaceuticals Limited Modified release tablet of pregabalin
PL235144B1 (pl) * 2014-06-03 2020-06-01 Univ Medyczny Im Piastow Slaskich We Wroclawiu Sposób wytwarzania tabletki flotacyjnej o przedłużonym oddziaływaniu substancji leczniczych z błoną śluzową żołądka oraz kompozycja farmaceutyczna
CN104561442B (zh) * 2014-10-23 2017-05-31 东莞市佳平装饰材料有限公司 一种核电用347奥氏体不锈钢的制备方法
JP6664080B2 (ja) * 2014-10-24 2020-03-13 ジエンス ヘンルイ メデイシンカンパニー リミテッドＪｉａｎｇｓｕ Ｈｅｎｇｒｕｉ Ｍｅｄｉｃｉｎｅ Ｃｏ．，Ｌｔｄ． プレガバリン徐放性製剤
JP6919119B2 (ja) * 2017-01-23 2021-08-18 日新製薬株式会社 ３位が置換されたγ−アミノ酪酸誘導体を含有する圧縮固形医薬組成物。
KR102039344B1 (ko) * 2017-02-01 2019-11-01 지엘팜텍주식회사 프레가발린 함유 경구용 서방성 삼중정제
KR102039345B1 (ko) * 2017-02-01 2019-11-01 지엘팜텍주식회사 프레가발린 함유 고팽윤성 서방성 삼중정제
US20230320989A1 (en) * 2020-07-20 2023-10-12 Sichuan Haisco Pharmaceutical Co., Ltd. Sustained-release pharmaceutical formulation of fused tricyclic ?-amino acid derivative and preparation method therefor
CN112245404A (zh) * 2020-11-02 2021-01-22 成都晶富医药科技有限公司 一种普瑞巴林胶囊及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT641330E (pt) 1992-05-20 2002-03-28 Univ Northwestern Analogos de gaba e de acido l-glutamico para o tratamento de doencas do sistema nervoso central
MXPA01002634A (es) * 1998-09-14 2002-06-04 Ranbaxy Lab Ltd Sistema de entrega que controla a una droga oralmente administrada proporcionando control en tiempo y espacial.
CA2356829A1 (en) * 2000-09-22 2002-03-22 Warner-Lambert Company Method for treating asthma using pregabalin
US20070184104A1 (en) * 2001-10-25 2007-08-09 Depomed, Inc. Gastric retentive gabapentin dosage forms and methods for using same
CA2491665A1 (fr) * 2004-12-24 2006-06-24 Louis Cartilier Formulation de comprime pour liberation soutenue de principe actif
WO2007048223A2 (en) * 2005-10-25 2007-05-03 Pharmascience Inc. A gastric retention drug delivery system
US20070092565A1 (en) * 2005-10-25 2007-04-26 Pharmascience Inc. Gastric retention drug delivery system
NL2000281C2 (nl) * 2005-11-02 2007-08-07 Pfizer Prod Inc Vaste farmaceutische samenstellingen die pregabaline bevatten.
JP2009522294A (ja) * 2005-12-29 2009-06-11 デポメッド， インコーポレイテッド 胃保持型ガバペンチン投薬形態およびその使用方法
ZA200901162B (en) * 2006-09-04 2010-06-30 Panacea Biotec Ltd Programmable buoyant delivery technology
CA2673336A1 (en) * 2006-12-21 2008-06-26 Xenoport, Inc. Levodopa dimethyl-substituted diester prodrugs, compositions, and methods of use
US20110268666A1 (en) * 2008-09-29 2011-11-03 Yissum Research Development Company of the Research University of Jerusalem, Ltd. Novel gastroretentive delivery system
EP3045043B1 (en) * 2009-02-26 2020-04-29 Relmada Therapeutics, Inc. Extended release oral pharmaceutical compositions of 3-hydroxy-n-methylmorphinan and method of use
CN103702664B (zh) * 2011-07-26 2016-10-19 柳韩洋行 通过两相控释系统的含普瑞巴林的缓释片

Similar Documents

Publication Publication Date Title
JP2013535477A5 (enExample)
CN109072050A (zh) 一种高效环保型抑尘剂及其制备方法、应用
JP2018040002A5 (enExample)
HRP20180965T1 (hr) Formulacija lijeka s produženim otpuštanjem
JP2016525572A5 (enExample)
JP2012140433A5 (enExample)
IL225640A (en) Benzimidazole Derivatives, Pharmaceutical Preparations Containing Them, Processes for their Preparation and Uses as Respiratory Systemic Viral Inhibitors
EP2600849A4 (en) FILM-FORMING COMPOSITION FOR SOFT CAPSULES
JP2015516240A5 (enExample)
WO2010084157A8 (en) Multifunctional stealth nanoparticles for biomedical use
JP2013010803A5 (enExample)
JP2014167010A5 (enExample)
WO2010082220A3 (en) Sustained release pharmaceutical composition of quetiapine and process for preparation thereof
CN109415361A (zh) 丙烯酸类衍生物及其制备方法和其在医药上的用途
JP2017520577A5 (enExample)
JP2012031240A5 (enExample)
JP2016529286A5 (enExample)
JP2013535251A5 (enExample)
JP2011520594A5 (enExample)
MX2012001691A (es) Composiciones de linaclotida que se desintegran oralmente.
IN2014DE00037A (enExample)
JP2014122166A5 (enExample)
JP2013216719A5 (enExample)
JP2011513393A5 (enExample)
WO2007100822A3 (en) Fluvastatin sodium pharmaceutical compositions